KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Tax Provisions (2016 - 2025)

Globus Medical (GMED) has disclosed Tax Provisions for 15 consecutive years, with $28.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 1658.16% year-over-year to $28.6 million, compared with a TTM value of $67.2 million through Dec 2025, up 278.85%, and an annual FY2025 reading of $67.2 million, up 278.85% over the prior year.
  • Tax Provisions was $28.6 million for Q4 2025 at Globus Medical, up from $25.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $28.6 million in Q4 2025 and bottomed at -$14.7 million in Q2 2025.
  • Average Tax Provisions over 5 years is $10.6 million, with a median of $11.3 million recorded in 2021.
  • Peak annual rise in Tax Provisions hit 2057.39% in 2025, while the deepest fall reached 192.74% in 2025.
  • Year by year, Tax Provisions stood at $4.7 million in 2021, then soared by 155.21% to $12.1 million in 2022, then decreased by 17.35% to $10.0 million in 2023, then crashed by 118.45% to -$1.8 million in 2024, then skyrocketed by 1658.16% to $28.6 million in 2025.
  • Business Quant data shows Tax Provisions for GMED at $28.6 million in Q4 2025, $25.0 million in Q3 2025, and -$14.7 million in Q2 2025.